Thursday, 02 April 2020

China News

  • GSK executives confessed to bribery charges: China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

    Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's security ministry has said that those involved have confessed to 'serio...Read more

  • J&J puts all Chinese units under single local chairman

    China |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

    Singapore: The business heads of Johnson & Johnson's (J&J) three Chinese operations would report to one local chairman from next month. This move has been made by the firm in an eff...Read more

  • China develops revolutionary TCM migraine medication

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2012

    Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine tablet, which demonstrated an effective rate of 96.5 percent in clinica...Read more

  • Can-Fite APIs to be manufactured by China CRO

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2013

    Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF102 are up-scaled and manufactured by Chemspec, a leading Chinese CRO....Read more

  • X-Change to launch Phytiva in China, SE Asia

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jan, 2013

    Singapore: X-Change, a US-based boutique company whose niche is extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, has been in discussions with ...Read more

  • OrbusNeich launches dual therapy heart stent

    China |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2013

    Singapore: Hong Kong-based OrbusNeich has launched dual therapy stent to address the challenges of delayed healing of the coronary artery associated with monotherapy drug eluting stents (DE...Read more

  • China vitamin C manufacturer fined by US court

    China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Mar, 2013

    Singapore: A US court has fined North China Pharmaceutical (NCPC), a vitamin C manufacturer and antibiotics supplier, $162 million for price fixing. This is the first time that a Chinese dr...Read more

  • Daewoong buys China's Liaoning Baifeng for $20 mn

    China |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Daewoong Pharmaceutical is going to acquire Liaoning Baifeng, a Shenyang (Liaoning Province)-based manufacturer of drug materials, and invest up to $20 million (18 billion won) t...Read more

  • Charles River grows $286 mn in Q1 2013

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 02 May, 2013

    Singapore: Charles River Laboratories has reported an increase of 1.8 percent in first quarter of 2013, clocking $286.0 million as compared to 2012. For the quarter, net sales from continui...Read more

  • Shenzhen Accord all set to go beyond China

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2012

    China is undergoing healthcare reforms and, in the process, industry regulations are becoming strict. Adopting a new business strategy to lead in the changing business environment, Shenzhen...Read more

  • India, China top 2013's GMP failures: EMA

    China |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2014

    Singapore: In a bid to bring about transparency, the European Medicines Agency (EMA) has released the public version of the EudraGMDP database to put together the statements of non-complian...Read more

  • Dehaier reports decrease in revenue in Q3'12

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: Dehaier Medical Systems, an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, reported a decrease in rev...Read more

  • MedImmune, WuXi form joint venture

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

    Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a research and development outsourcing company, have formed a joint venture to develop and commercialize MEDI...Read more

  • HUYA, Sanzao Park partner for drug development

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partnership with Zhuhai Sanzao Science and Technology Industrial Park. The ...Read more

  • Baird Capital invests in Kedu Healthcare in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

    Singapore: Investment firm Baird Capital has invested in Kedu Healthcare, one of China's largest independent medical equipment service providers formed by GE Healthcare executive Mr James N...Read more

  • Police: Sexual favours spurred GSK's $1.5 bn China sales

    China |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2013

    Singapore: A day after making the allegations against GlaxoSmithKline's senior executives public, China's Public Security Ministry has said that bribes paid to hospitals, health officials a...Read more

  • Asia bags $6.6 bn M&A deals in 2013

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 28 Mar, 2014

    Singapore: The Asia-Pacific (APAC) region attracted around 101 M&A deals in pharma, medical, and biotech industry in the first half of 2013, marking an increase of 29.5 percent from H1 ...Read more

  • CyberKnife System earns over 1 mn in revenue

    China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2012

    Singapore: CyberKnife Robotic Radiosurgery System, located in Changhai Hospital, along with da Vinci Surgical System, has treated over 170 patients since the start of its trial run in Febru...Read more